BRIEF-Taysha Gene Therapies Q3 Net Income USD -39.128 Million
Nov 12 (Reuters) - Taysha Gene Therapies Q3 operating income USD -41.872 million.
Related stories
Paysafe Stock Plunges Post Q3 Report — CEO Says Market Headwinds Exceeded Expectations
Paysafe (PSFE) shares were on track to hit all-time lows on Thursday, falling approximately 30% in premarket trading after the payments company reported weaker-than-expected third
L impact | FX | Nov 12, 2026, 02:13 PM UTC
Convera Says Fed Rate-Rise Expectations Should Support Dollar
Convera’s market insights team says stronger-than-expected U.S. jobs and inflation data have raised expectations for further Fed rate increases, likely keeping the dollar elevated.
M impact | FX | Nov 12, 2026, 01:09 PM UTC
Russian gold and forex reserves rise to $724.3 billion
The Russian central bank reported reserves of $724.3 billion in the latest week, versus $721.6 billion in the previous week.
M impact | FX | Nov 12, 2026, 01:00 PM UTC
ING Sees Euro at Risk of Falling Below $1.10
ING's Francesco Pesole says the euro could fall below $1.10 in coming days after reaching an 18-month low of $1.1065 overnight, according to LSEG. A decisive break would probably r
M impact | FX | Nov 12, 2026, 09:42 AM UTC
Dollar Holds Near 19-Month High as Rate Divergence Stays in Focus
M impact | FX | Nov 12, 2026, 09:33 AM UTC
US Dollar Climbs on Fed Rate Hike Expectations, Currencies Direct Says
The US dollar climbed as expectations for a Federal Reserve rate hike increased, according to Currencies Direct.
M impact | FX | Nov 12, 2026, 08:57 AM UTC